Becker W J
University of Calgary, Alberta, Canada.
Can J Neurol Sci. 1997 Feb;24(1):16-21. doi: 10.1017/s031716710002103x.
Initiation of oral contraceptive (OC) therapy in migraine may worsen pre-existing migraine or change the pattern of the individual migraine attacks. Many women experience no change in their migraine and a few show improvement. Evidence is accumulating that migraine increases ischemic stroke risk and that this risk is higher in migraine with aura than in migraine without aura. OCs also increase stroke risk, and the increased stroke risk attributable to each of migraine and OC therapy may be additive. The risk of ischemic stroke in young women is very low and likely remains acceptably low in young women with migraine without aura and in those with a simple migraine aura when OCs are prescribed. However, the presence of a complex or prolonged migraine aura, or of additional stroke risk factors such as increased age, smoking, and hypertension likely increases the ischemic stroke risk further in patients with migraine when OCs are prescribed. Whether OCs can be prescribed safely for the patient with migraine depends upon many factors including patient age, type of migraine, and the presence or absence of other stroke risk factors.
偏头痛患者开始口服避孕药(OC)治疗可能会使原有的偏头痛恶化或改变个体偏头痛发作的模式。许多女性的偏头痛没有变化,少数女性的偏头痛症状有所改善。越来越多的证据表明,偏头痛会增加缺血性中风的风险,并且有先兆偏头痛的这种风险高于无先兆偏头痛。口服避孕药也会增加中风风险,偏头痛和口服避孕药治疗各自增加的中风风险可能会叠加。年轻女性缺血性中风的风险非常低,对于无先兆偏头痛的年轻女性以及有单纯偏头痛先兆的女性,开具口服避孕药时其风险可能仍处于可接受的低水平。然而,存在复杂或持续时间较长的偏头痛先兆,或存在其他中风风险因素,如年龄增加、吸烟和高血压,在开具口服避孕药时,可能会进一步增加偏头痛患者的缺血性中风风险。偏头痛患者能否安全地开具口服避孕药取决于许多因素,包括患者年龄、偏头痛类型以及其他中风风险因素的有无。